Skip to main content
. 2022 Jan 3;11:797007. doi: 10.3389/fonc.2021.797007

Figure 6.

Figure 6

Expressions of TPD52, KLF9, miR-223, and PKCϵ in blood of cervical cancer patients. (A) TPD52 expression was increased 23-fold. (B) KLF9 expression was decreased 0.4-fold. (C) miR-223 expression was increased 2-fold. (D) PKCϵ decreased 0.05-fold. Fold change is plotted on the y-axis and study groups on the x-axis. Illustrative data are presented as the mean ± SEM of triplicate experimentations. Statistical significance was measured by ordinary two-way ANOVA (****p < 0.0001).